Concepedia
Statistics
Publications
6
Citations
273
H-Index
Active since
2011
Affiliations
Harvard University(Current)
Dana-Farber Cancer Institute
Matt L. Harlow is an author at Harvard University specializing in cell biology, medicine, and pathology.
Top concepts
MedicineCell BiologyPathologyTumor BiologyCancer GeneticsSystems BiologyNatural SciencesMolecular BiologyCancer Cell BiologyTranscriptional Regulation
Publications per year
2011–2021
Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus
Matt L. Harlow, Nichole Maloney, Joseph T. Roland et al. · Cancer Research · 2016 · 87 citations · Full text
Tumor Biology, Transcriptional Regulation, Ewing Sarcoma +13
Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner
Matt L. Harlow, Maggie H. Chassé, Elissa A. Boguslawski et al. · Clinical Cancer Research · 2019 · 53 citations · Full text
Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor
Andrew J. Murphy, Xiang Chen, Emília M. Pinto et al. · Nature Communications · 2019 · 50 citations · Full text
Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma
Patrick J. Grohar, Sun Tae Kim, Guillermo O. Rangel Rivera et al. · Cell Reports · 2016 · 49 citations · Full text
Pathology, Molecular Biology, Splicing Variant +17
Chromatin modifying protein 1A (Chmp1A) of the endosomal sorting complex required for transport (ESCRT)-III family activates ataxia telangiectasia mutated (ATM) for PanC-1 cell growth inhibition
Sumanth Manohar, Matt L. Harlow, H. V. Nguyen et al. · Cell Cycle · 2011 · 18 citations · Full text
Genetics, Family Activates, Molecular Biology +17
1–5 of 6